Defining the genital immune correlates of protection against HIV acquisition: Co-infections and other potential confounders

Sexually Transmitted Infections

Volumn 87, Issue 2, 2011, Pages 125-130

  Kaul, Rupert ^a,b,c   Ball, T B ^b,d,e   Hirbod, T ^a,f  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF NAIROBI   (Kenya)

^c UNIVERSITY HEALTH NETWORK   (Canada)

^d PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^e UNIVERSITY OF MANITOBA   (Canada)

^f KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA DEFENSIN; ALPHA INTERFERON; BETA DEFENSIN; CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; CXCL9 CHEMOKINE; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; LACTOFERRIN; MACROPHAGE CHEMOTACTIC FACTOR; MICROBICIDE; RANTES; SECRETORY LEUKOCYTE PROTEINASE INHIBITOR;

ANTIVIRAL ACTIVITY; COHORT ANALYSIS; DEMOGRAPHY; DISEASE PREDISPOSITION; HIGH RISK BEHAVIOR; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNITY; IMMUNOLOGY; IN VITRO STUDY; MEDICAL RESEARCH; MIXED INFECTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; REVIEW; SEXUAL BEHAVIOR; SEXUAL TRANSMISSION;

DISEASE SUSCEPTIBILITY; FEMALE; HIV INFECTIONS; HIV SERONEGATIVITY; HUMANS; IMMUNITY, MUCOSAL; IMMUNOLOGIC FACTORS; MALE; PROSPECTIVE STUDIES; RNA, VIRAL;

EID: 79952104976     PISSN: 13684973     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/sti.2009.040931     Document Type: Review

References (45)

1. Hladik F, McElrath MJ. Setting the stage: host invasion by HIV. Nat Rev Immunol 2008;8:447-57.
2. Kimani J, Kaul R, Nagelkerke NJ, et al. Reduced rates of HIV acquisition during unprotected sex by Kenyan female sex workers predating population declines in HIV prevalence. AIDS 2008;22:131-7.
3. Rerks-Ngarm S, Pitisuttithum P, Nitayaphan S, et al; MOPH-TAVEG Investigators. Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. N Engl J Med 2009;361:2209-20.
4. Nagelkerke NJ, de Vlas SJ, Jha P, et al. Heterogeneity in host HIV susceptibility as a potential contributor to recent HIV prevalence declines in Africa. AIDS 2009;23:125-30.
5. Quinn TC, Wawer MJ, Sewankambo N, et al. Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. N Engl J Med 2000;342:921-9.
6. Donnell D, Baeten JM, Kiarie J, et al; Partners in Prevention HSV/HIV Transmission Study Team. Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis. Lancet 2010;375:2092-8.
7. Cohen MS, Gay CL. Treatment to prevent transmission of HIV-1. Clin Infect Dis 2010;50(Suppl 3):S85-95.
8. Sheth PM, Kovacs C, Kemal KS, et al; Toronto Mucosal Immunology Group. Persistent HIV RNA shedding in semen despite effective antiretroviral therapy. AIDS 2009;23:2050-4.
9. Cu-Uvin S, Delong AK, Venkatesh KK, et al. Genital tract HIV-1 RNA shedding among women with below detectable plasma viral load. AIDS 2010;24:2489-97.
10. Attia S, Egger M, Muller M, et al. Sexual transmission of HIV according to viral load and antiretroviral therapy: systematic review and meta-analysis. AIDS 2009;23:1397-404.
11. Lingappa JR, Hughes JP, Wang RS, et al; Partners in Prevention HSV/HIV Transmission Study Team. Estimating the impact of plasma HIV-1 RNA reductions on heterosexual HIV-1 transmission risk. PLoS One 2010;5:e12598.
12. Wilson DP, Law MG, Grulich AE, et al. Relation between HIV viral load and infectiousness: a model-based analysis. Lancet 2008;372:314-20.
13. Cohen MS, Hoffman IF, Royce RA, et al. Reduction of concentration of HIV-1 in semen after treatment of urethritis: implications for prevention of sexual transmission of HIV-1. AIDSCAP Malawi Research Group. Lancet 1997;349:1868-73.
14. Sheth PM, Danesh A, Sheung A, et al. Disproportionately high semen shedding of HIV is associated with compartmentalized cytomegalovirus reactivation. J Infect Dis 2006;193:45-8.
15. Coleman JS, Hitti J, Bukusi EA, et al. Infectious correlates of HIV-1 shedding in the female upper and lower genital tracts. AIDS 2007;21:755-9.
16. Sha BE, Zariffard MR, Wang QJ, et al. Female genital-tract HIV load correlates inversely with Lactobacillus species but positively with bacterial vaginosis and Mycoplasma hominis. J Infect Dis 2005;191:25-32.
17. Gray RH, Wawer MJ, Brookmeyer R, et al; Rakai Project Team. Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda. Lancet 2001;357:1149-53.
18. Fowke KR, Nagelkerke NJ, Kimani J, et al. Resistance to HIV-1 infection among persistently seronegative prostitutes in Nairobi, Kenya. Lancet 1996;348:1347-51.
19. Kulkarni PS, Butera ST, Duerr AC. Resistance to HIV-1 infection: lessons learned from studies of highly exposed persistently seronegative (HEPS) individuals. AIDS Rev 2003;5:87-103.
20. Kaul R, Kimani J, Nagelkerke NJ, et al. Reduced HIV risk-taking and low HIV incidence after enrollment and risk-reduction counseling in a sexually transmitted disease prevention trial in Nairobi, Kenya. J Acquir Immune Defic Syndr 2002;30:69-72.
21. Yadav G, Saskin R, Ngugi E, et al; Kibera HIV Study Group. Associations of sexual risk taking among Kenyan female sex workers after enrolment in an HIV-1 prevention trial. J Acquir Immune Defic Syndr 2005;38:329-34.
22. Xia Q, Molitor F, Osmond DH, et al. Knowledge of sexual partner's HIV serostatus and serosorting practices in a California population-based sample of men who have sex with men. AIDS 2006;20:2081-9.
23. Wira C, Fahey J, Wallace P, et al. Effect of the menstrual cycle on immunological parameters in the human female reproductive tract. J Acquir Immune Defic Syndr 2005;38(Suppl 1):S34-6.
24. Iqbal SM, Kaul R. Mucosal innate immunity as a determinant of HIV susceptibility. Am J Reprod Immunol 2008;59:44-54.
25. Hirbod T, Nilsson J, Andersson S, et al. Upregulation of interferon-alpha and RANTES in the cervix of HIV-1-seronegative women with high-risk behavior. J Acquir Immune Defic Syndr 2006;43:137-43.
26. Levinson P, Kaul R, Kimani J, et al; Kibera HIV Study Group. Levels of innate immune factors in genital fluids: association of alpha defensins and LL-37 with genital infections and increased HIV acquisition. AIDS 2009;23:309-17.
27. Iqbal SM, Ball TB, Kimani J, et al. Elevated T cell counts and RANTES expression in the genital mucosa of HIV-1-resistant Kenyan commercial sex workers. J Infect Dis 2005;192:728-38.
28. Kaul R, Plummer FA, Kimani J, et al. HIV-1-specific mucosal CD8+ lymphocyte responses in the cervix of HIV-1-resistant prostitutes in Nairobi. J Immunol 2000;164:1602-11.
29. Farquhar C, VanCott TC, Mbori-Ngacha DA, et al. Salivary secretory leukocyte protease inhibitor is associated with reduced transmission of human immunodeficiency virus type 1 through breast milk. J Infect Dis 2002;186:1173-6.
30. Iqbal SM, Ball TB, Levinson P, et al. Elevated elafin/trappin-2 in the female genital tract is associated with protection against HIV acquisition. AIDS 2009;23:1669-77.
31. Hirbod T, Kaul R, Reichard C, et al. HIV-neutralizing immunoglobulin A and HIV-specific proliferation are independently associated with reduced HIV acquisition in Kenyan sex workers. AIDS 2008;22:727-35.
32. Card CM, McLaren PJ, Wachihi C, et al. Decreased immune activation in resistance to HIV-1 infection is associated with an elevated frequency of CD4(+)CD25(+) FOXP3(+) regulatory T cells. J Infect Dis 2009;199:1318-22.
33. Ball TB, Ji H, Kimani J, et al. Polymorphisms in IRF-1 associated with resistance to HIV-1 infection in highly exposed uninfected Kenyan sex workers. AIDS 2007;21:1091-101.
34. Wira CR, Fahey JV, Sentman CL, et al. Innate and adaptive immunity in female genital tract: cellular responses and interactions. Immunol Rev 2005;206:306-35.
35. Robertson SA, Guerin LR, Bromfield JJ, et al. Seminal fluid drives expansion of the CD4+CD25+ T regulatory cell pool and induces tolerance to paternal alloantigens in mice. Biol Reprod 2009;80:1036-45.
36. Baltzer H, Chege D, Rebbapragada A, et al. Relative HIV resistance in Kenyan sex workers is not due to an altered prevalence or mucosal immune impact of herpes simplex virus type 2 infection. Curr HIV Res 2009;7:504-7.
37. Rebbapragada A, Wachihi C, Pettengell C, et al. Negative mucosal synergy between herpes simplex type 2 and HIV in the female genital tract. Aids 2007;21:589-98.
38. Zhu J, Hladik F, Woodward A, et al. Persistence of HIV-1 receptor-positive cells after HSV-2 reactivation is a potential mechanism for increased HIV-1 acquisition. Nat Med 2009;15:886-92.
39. Eggena MP, Barugahare B, Okello M, et al. T cell activation in HIV-seropositive Ugandans: differential associations with viral load, CD4+ T cell depletion, and coinfection. J Infect Dis 2005;191:694-701.
40. Koesters SA, Matu L, Kiama P, et al. Elevation of immune activation in Kenyan women is associated with alterations in immune function: implications for vaccine development. J Clin Immunol 2004;24:702-9.
41. Rizzardini G, Trabattoni D, Saresella M, et al. Immune activation in HIV-infected African individuals. Italian-Ugandan AIDS cooperation program. AIDS 1998;12:2387-96.
42. Cohen CR, Moscicki AB, Scott ME, et al. Increased levels of immune activation in the genital tract of healthy young women from sub-Saharan Africa. AIDS 2010;24:2069-74.
43. Kaul R, Rebbapragada A, Hirbod T, et al. Genital levels of soluble immune factors with anti-HIV activity may correlate with increased HIV susceptibility. AIDS 2008;22:2049-51.
44. Li Q, Estes JD, Schlievert PM, et al. Glycerol monolaurate prevents mucosal SIV transmission. Nature 2009;458:1034-8.
45. Dobson-Belaire WN, Rebbapragada A, Malott RJ, et al. Neisseria gonorrhoeae effectively blocks HIV-1 replication by eliciting a potent TLR9-dependent interferonalpha response from plasmacytoid dendritic cells. Cell Microbiol 2010;12:1703-17.